USFDA APPLICATION NUMBER - 21131 / DOSAGE - SOLUTION;INTRAVENOUS - 600MG/300ML (2MG/ML)
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
LINEZOLID(UNII: ISQ9I6J12J) (LINEZOLID - UNII:ISQ9I6J12J) | LINEZOLID | 600mg in 300 |
Inactive Ingredients
Ingredient Name | Hospira, Inc. | Teva Parenteral Medicines, Inc. | Fresenius Kabi Norge As | Mylan Institutional LLC |
---|---|---|---|---|
ANHYDROUS CITRIC ACID(XF417D3PSL) | ||||
CITRIC ACID MONOHYDRATE(2968PHW8QP) | ||||
DEXTROSE MONOHYDRATE(LX22YL083G) | ||||
DEXTROSE, UNSPECIFIED FORM(IY9XDZ35W2) | ||||
HYDROCHLORIC ACID(QTT17582CB) | ||||
SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR) | ||||
SODIUM HYDROXIDE(55X04QC32I) | ||||
TRISODIUM CITRATE DIHYDRATE(B22547B95K) | ||||
WATER(059QF0KO0R) |
LOOKING FOR A SUPPLIER?